Skip to main content

. 1994 May;32(5):1415–1416. doi: 10.1128/jcm.32.5.1415-1416.1994

Treatment of late Lyme disease: a challenge to accept.

J A López-Andreu, J Ferrís, C A Canosa, J V Sala-Lizárraga

PMCID: PMC263721 PMID: 8051284

1415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ackermann R., Gollmer E., Rehse-Küpper B. Progressive Borrelien-Enzephalomyelitis. Chronische Manifestation der Erythema-chronicum-migrans-Krankheit am Nervensystem. Dtsch Med Wochenschr. 1985 Jun 28;110(26):1039–1042. doi: 10.1055/s-2008-1068956. [DOI] [PubMed] [Google Scholar]
Halperin J. J., Heyes M. P. Neuroactive kynurenines in Lyme borreliosis. Neurology. 1992 Jan;42(1):43–50. doi: 10.1212/wnl.42.1.43. [DOI] [PubMed] [Google Scholar]
Halperin J. J., Kaplan G. P., Brazinsky S., Tsai T. F., Cheng T., Ironside A., Wu P., Delfiner J., Golightly M., Brown R. H. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol. 1990 May;47(5):586–594. doi: 10.1001/archneur.1990.00530050110021. [DOI] [PubMed] [Google Scholar]
Liegner K. B. Lyme disease: the sensible pursuit of answers. J Clin Microbiol. 1993 Aug;31(8):1961–1963. doi: 10.1128/jcm.31.8.1961-1963.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
Perrine S. P., Vichinsky E., Faller D. V. Hematopoietic hormones: from cloning to clinic. Am J Pediatr Hematol Oncol. 1989 Fall;11(3):268–275. [PubMed] [Google Scholar]
Roilides E., Pizzo P. A. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis. 1992 Sep;15(3):508–524. doi: 10.1093/clind/15.3.508. [DOI] [PubMed] [Google Scholar]
Spach D. H., Liles W. C., Campbell G. L., Quick R. E., Anderson D. E., Jr, Fritsche T. R. Tick-borne diseases in the United States. N Engl J Med. 1993 Sep 23;329(13):936–947. doi: 10.1056/NEJM199309233291308. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES